Call Options

31 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $87 Million - $101 Million
782,600 Added 1308.7%
842,400 $95.7 Million
Q2 2024

Aug 14, 2024

SELL
$123.8 - $132.96 $34.4 Million - $36.9 Million
-277,600 Reduced 82.28%
59,800 $7.4 Million
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $19.5 Million - $22.7 Million
-171,900 Reduced 33.75%
337,400 $44.5 Million
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $35.6 Million - $38.7 Million
-355,400 Reduced 41.1%
509,300 $55.5 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $11.5 Million - $12.8 Million
-111,800 Reduced 11.45%
864,700 $89 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $9.41 Million - $10.3 Million
86,600 Added 9.73%
976,500 $113 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $53.2 Million - $59.3 Million
-516,500 Reduced 36.72%
889,900 $94.7 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $40.6 Million - $52 Million
-464,200 Reduced 24.82%
1,406,400 $156 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $52.5 Million - $59 Million
-621,200 Reduced 24.93%
1,870,600 $161 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $1 Million - $1.14 Million
12,000 Added 0.48%
2,491,800 $227 Million
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $51.5 Million - $57.7 Million
-700,700 Reduced 22.03%
2,479,800 $203 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $101 Million - $126 Million
1,394,400 Added 78.07%
3,180,500 $244 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $128 Million - $141 Million
1,786,100 New
1,786,100 $134 Million
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $67.3 Million - $74 Million
-939,000 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $11.2 Million - $12.4 Million
-159,500 Reduced 14.52%
939,000 $73 Million
Q1 2021

May 14, 2021

BUY
$68.86 - $81.11 $7.34 Million - $8.65 Million
106,600 Added 10.75%
1,098,500 $84.7 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $71.2 Million - $79 Million
991,900 New
991,900 $81.1 Million
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $117 Million - $130 Million
-1,632,400 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $8.75 Million - $9.91 Million
-119,500 Reduced 6.82%
1,632,400 $135 Million
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $42.9 Million - $48.8 Million
609,300 Added 53.33%
1,751,900 $135 Million
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $75.7 Million - $105 Million
-1,194,600 Reduced 51.11%
1,142,600 $87.9 Million
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $143 Million - $161 Million
1,839,700 Added 369.79%
2,337,200 $213 Million
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $13.8 Million - $15 Million
180,900 Added 57.14%
497,500 $40 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $11.1 Million - $12.9 Million
158,700 Added 100.51%
316,600 $26.5 Million
Q1 2019

May 15, 2019

SELL
$69.58 - $79.36 $22.3 Million - $25.4 Million
-320,200 Reduced 66.97%
157,900 $13.1 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $848,119 - $984,229
-13,000 Reduced 2.65%
478,100 $36.5 Million
Q3 2018

Nov 14, 2018

SELL
$57.69 - $67.84 $2.32 Million - $2.73 Million
-40,300 Reduced 7.58%
491,100 $34.8 Million
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $691,288 - $812,192
-13,600 Reduced 2.5%
531,400 $32.3 Million
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $14.3 Million - $16.6 Million
-279,900 Reduced 33.93%
545,000 $29.7 Million
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $2.06 Million - $2.46 Million
39,900 Added 5.08%
824,900 $46.4 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $46.1 Million - $49.6 Million
785,000
785,000 $50.3 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $244B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.